Notably, the correlation of ADAM8 with tumour progression, metastasis, and chemoresistance in various invasive cancers, including pancreatic cancer (Yu et al., 2019), breast cancer (Conrad et al., 2018), and lung cancer (Ishikawa et al., 2004), has been previously reported. This evidence concerns the gene ADAM8 and pancreatic neoplasm.